用于肿瘤光动力/光热协同治疗的低氧依赖性聚合物囊泡研究
批准号:
51873143
项目类别:
面上项目
资助金额:
59.0 万元
负责人:
陈华兵
依托单位:
学科分类:
生物医用有机高分子材料
结题年份:
2022
批准年份:
2018
项目状态:
已结题
项目参与者:
杨涛、汪媛、翟艳华、李明、刘玲、宋雪、王璐
中文摘要
光敏剂的胞内递送和氧依赖性是肿瘤光动力治疗中的难点。本项目拟合成pH、光氧化响应的聚乙二醇-聚己内酯-聚吡啶酮三臂聚合物,构建载双功能光敏剂Bodipy和吡啶酮内过氧化物的聚合物囊泡。通过对囊泡理化性质的调控,增强其肿瘤靶向和细胞摄取能力;囊泡进入肿瘤细胞溶酶体后,缩醛键的酸响应解离能有效促进Bodipy的持续释放;在光治疗中,囊泡中的Bodipy能同时产生单线态氧和光热效应,单线态氧在诱导光动力治疗的同时,可迅速诱导囊泡中缩硫酮的光氧化解离以及溶酶体的破裂,进一步促进Bodipy的快速释放和胞浆转运,增强其光动力治疗作用;而光热效应则在降低Bodipy耗氧量、产生光热治疗的同时,能有效诱导囊泡中吡啶酮内过氧化物快速释放单线态氧,产生非氧依赖的光动力治疗效应;最终实现低氧依赖的肿瘤光动力、光热协同治疗。本项目对探索光敏剂的高效递送及在乏氧肿瘤治疗中的应用具有重要的理论意义及实用价值。
英文摘要
It is difficult to achieve the intracellular delivery of photosensitizers and overcome their oxygen dependence in cancer photodynamic therapy (PDT). In this application, we propose to synthesize pH- and photo-oxidation-responsive poly (ethylene glycol)-poly(caprolactone)-poly(pyridone) terpolymer, and further construct the polymeric vesicles encapsulating both bifunctional Bodipy photosensitizer and pyridone-derived endoperoxide. The physicochemical properties of these vesicles are optimized to improve their tumor accumulation and cellular uptake. Upon their endocytosis into the lysosomes, the acetal group in the vesicles can be decomposed in response to the lysosomal acidity and thus trigger the continuously enhanced release of Bodipy from the vesicles. Meanwhile, Bodipy in the vesicles can generate both singlet oxygen and photothermal effect under light treatment. Their singlet oxygen not only generates PDT efficacy, but also induces the cleavage of thioketal group in the vesicles in response to the photo-oxidation and simultaneous lysosomal rupture, which further result in the quick release of Bodipy and subsequent cytoplasmic translocation, followed by their enhanced PDT efficacy. Moreover, their photothermal effect is also able to cause photothermal therapy of Bodipy with reduced oxygen depletion, and simultaneous singlet oxygen release from pyridone-derived endoperoxide that can produce oxygen-independent PDT efficacy. Thus, these vesicles can finally achieve the synergistically photodynamic and photothermal cancer therapies with reduced oxygen dependence. This work is very valuable to explore highly efficient intracellular delivery of photosensitizers and their uses in treating hypoxia tumors.
如何有效调控光敏剂的光转换行为是当前肿瘤光治疗研究面临的关键挑战。本项目构建了光转换性能可调控的低氧依赖性载光敏剂高分子纳米粒,发展了光热、光动力协同治疗策略,显著增强了抗肿瘤治疗效果。利用具有空腔结构的单分子白蛋白为模板,共负载吲哚菁绿和吡啶酮类化合物,构建了自携带单线态氧的高分子纳米粒,利用其长效光动力作用,显著降低了光治疗对氧的依赖性,大幅提升了肿瘤光治疗效果;在此基础上,利用碘原子及中性Ir复合物进一步调控了BODIPY类光敏剂的光动力及光热转换性能,构建具有低氧依赖性的高分子纳米粒,实现了原位乳腺癌及转移灶的光热、光动力协同治疗作用。在本项目的资助下,项目负责人发表SCI论文10篇,其中在Advanced Materials(4篇)、Advanced Healthcare Materials(1篇)、Journal of Controlled Release(2篇)等期刊发表通讯作者论文7篇,项目编号第一标注论文4篇;获得授权中国发明专利3项。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
Amphiphilic BODIPY dye aggregates in polymeric micelles for wavelength-dependent photo-induced cancer therapy
两亲性 BODIPY 染料聚集在聚合物胶束中,用于波长依赖性光诱导癌症治疗
DOI:
10.1039/d0tb00609b
发表时间:
2020
期刊:
Journal of Materials Chemistry B
影响因子:
7
作者:
[Yan Ziling, Wang Mengya, Shi Mengke, He Yang, Zhang Yi, Qiu Shihong, Yang Hong, Chen Huabing, He Hui, Guo Zhengqing]
通讯作者:
Guo Zhengqing
pH-activatable copper-biomineralized proenzyme for synergistic chemodynamic/ chemo-immunotherapy against aggressive cancers
pH 可激活的铜生物矿化酶原,用于针对侵袭性癌症的协同化学动力学/化学免疫疗法
DOI:
10.1002/adma.202210201
发表时间:
2023
期刊:
Advanced Materials
影响因子:
29.4
作者:
[Li Ting, Zhang Ying, Zhu Jie, Zhang Fangrui, Xu An'an, Zhou Tian, Li Yaoqi, Liu Ming, Ke Hengte, Yang Tao, Tang Yong'an, Tao Jing, Miao Liyan, Deng Yibin, Chen Huabing]
通讯作者:
Chen Huabing
Ultrastable Near-Infrared Nonlinear Organic Chromophore Nanoparticles with Intramolecular Charge Transfer for Dually Photoinduced Tumor Ablation.
具有分子内电荷转移的超稳定近红外非线性有机发色团纳米粒子,用于双重光诱导肿瘤消融
DOI:
10.1002/adhm.202001042
发表时间:
2020
期刊:
Advanced Healthcare Materials
影响因子:
10
作者:
[Zhang Yi, Shi Mengke, Yan Zhangren, Zhang Shao, Wang Mengya, Xu Han, Li Hongyu, Ying Yuchen, Qiu Shihong, Liu Jialei, Yang Hong, Chen Huabing, He Hui, Guo Zhengqing]
通讯作者:
Guo Zhengqing
Self-activated arsenic manganite nanohybrids for visible and synergistic thermo/immuno-arsenotherapy
用于可见和协同热/免疫砷疗法的自激活砷锰纳米杂化物
DOI:
10.1016/j.jconrel.2022.08.054
发表时间:
2022
期刊:
Journal of Controlled Release
影响因子:
10.8
作者:
[Zhai Yanhua, Liu ming, Yang Tao, Luo Jie, Wei Chaogang, Shen Junkang, Song Xue, Ke Hengte, Sun Peng, Guo Miao, Deng Yibing, Chen Huabing]
通讯作者:
Chen Huabing
Biomineralized Iron Oxide–Polydopamine Hybrid Nanodots for Contrast-Enhanced T1-Weighted Magnetic Resonance Imaging and Photothermal Tumor Ablation
生物矿化氧化铁与聚多巴胺混合纳米点用于增强 T1 加权磁共振成像和光热肿瘤消融
DOI:
10.1039/d1tb00032b
发表时间:
2021
期刊:
Journal of Materials Chemistry B
影响因子:
7
作者:
[Wang Ze'ai, Wang Yanfeng, Wang Yuan, Wei Chaogang, Deng Yibin, Chen Huabing, Shen Junkang, Ke Hengte]
通讯作者:
Ke Hengte
共 10 条
用于胰腺癌光免疫协同治疗的单分子白蛋白纳米粒及其增敏机制研究
-
批准号:32330060
-
项目类别:重点项目
-
资助金额:212万元
-
批准年份:2023
-
负责人:陈华兵
-
依托单位:
铂类药物蛋白纳米粒的仿生合成及在耐药肿瘤协同治疗中的应用
-
批准号:31671016
-
项目类别:面上项目
-
资助金额:64.0万元
-
批准年份:2016
-
负责人:陈华兵
-
依托单位:
用于肿瘤光热/分子靶向双向协同治疗的聚合物胶束研究
-
批准号:51473109
-
项目类别:面上项目
-
资助金额:83.0万元
-
批准年份:2014
-
负责人:陈华兵
-
依托单位:
用于肝转移瘤早期探测的可激活近红外荧光纳米探针研究
-
批准号:81202472
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈华兵
-
依托单位:
国内基金
海外基金